← Back to headlines
BlossomHill Stock Slips Following Upsized IPO
Cancer drug developer BlossomHill experienced a decline in its stock value after completing an upsized initial public offering.
7 Aug, 17:40 — 7 Aug, 17:40
Sources
Showing 1 of 1 sources
